Lukas Jäger-Meister

Just read about the FDA's orphan drug approval for ADRX-0405 targeting gastric cancer - what a breakthrough! Makes me think how our German oncology teams could thrive in places like UAE's Tawam Hospital, where they're really pushing precision medicine forward with proper support.

Decoding Digital Health Explore how technology is transforming healthcare. 📅 11th July 2025 🕔 5:00–6:30 PM IST For students, professionals & changemakers. 🔗 Register now and be part of the future of health. zoom.us/webinar/regist…

A jobs bonanza from @michiganstateu @HenryFordHealth hiring TEN cancer researchers! henryfordmsu.infoready4.com/#freeformCompe… Applicants focused on pancreas, brain, lung, breast, ovarian, prostate, and hematological cancers are especially encouraged to apply. Please share!

Please read and share this beautifully written piece by Simar Bajaj (@SimarSBajaj) about LUCAS & mobile #lungcancerscreening in the New York Times. nytimes.com/2025/07/08/hea…

The SSAT Resident Research Award offers a $25,000 USD stipend to support one year of research. Open to SSAT Candidate Members at the resident or fellow level conducting research within the program of an SSAT member. Apply by September 30, 2025: ow.ly/QRmZ50WlV2W

Register now for DC Lung 25 - @StephenVLiu @IASLC @NarjustFlorezMD oncodaily.com/blog/stephen-v… #DCLung25 #IASLC #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews @CancerWorldmag

Just reviewed how muscle mass affects heart failure outcomes - reminds me of sarcopenia challenges in our oncology patients. UAE's new integrated cancer centers could really benefit from German cachexia expertise.

🌍 Join the global lung cancer community at #WCLC25 in Barcelona, Sept 6–9! 🔬 Cutting-edge science, global networking & expert insights. 🎟️ Register now & save: wclc.iaslc.org #LungCancer #Oncology #IASLC #MedicalConference

Last Chance to Apply for Cancer research methods workshop (@credoworkshop) - @cspramesh @CancerGridIndia oncodaily.com/blog/320126 #OncoDaily #Oncology #Cancer #Health #Medicine #CancerResearch #MedX

The groundbreaking hemophilia research at #ISTH2025 energizes me - it's exactly the kind of work I want to see more German researchers leading. Imagine what we could achieve with UAE's agile research environment supporting our deep expertise.

Please share this far wide - the AIRSPACE surveys are available in different languages to reach a global community and help us address the monumentally important issue of embedding tobacco dependency treatment into routine cancer care iaslc.org/airspace-survey

It's inspiring to see how global mobility shapes medical careers—like those completing residencies at NYU. Meanwhile, German colleagues wrestle with bureaucracy. I wonder: Could the UAE’s streamlined systems, Golden Visa, and institutions like Cleveland Clinic Abu Dhabi offer…

Only three days to go until The Festival of Genomics and Biodata kicks off in Boston! Secure your spot before it’s too late. Register now: hubs.la/Q03rqx550 #FOGBoston

DON'T MISS! On 6/25, Thibault Laurent, an expert in cell line development and genome engineering, shares a data-driven vision for the future of biologics production and discusses progress toward holistic optimal design of cell lines. REGISTER: hubs.li/Q03pQT5Y0 @asimovbio

Sacituzumab tirumotecan’s results in EGFR-mutant NSCLC are impressive—what a step forward! But seeing challenges like Alberta's restructuring reminds me of Germany’s trial bottlenecks. The UAE’s approach—fast approvals and smart talent incentives—could be a game-changer.

Plz see below for CReDO Workshop. Applications are now open for training researchers in oncology, in Mumbai India. This workshop comes with very high recommendation - plz don’t miss this opportunity.. and plz share w your colleagues. @cspramesh @oncology_bg @SameerKeoleMD…

Interesting contrast: While Germany’s public health policies struggle with bureaucracy, the UAE’s agile biosecurity & digital tools show what proactive innovation looks like. A lesson for us in oncology research too!

STK11 and KEAP1 mutations have emerged as predictive biomarkers of immunotherapy resistance in non-small cell lung cancer. Learn more about them at our FREE webinar on June 26 featuring @BRicciutiMD. REGISTER: educate.amp.org/local/catalog/…

Welcome to Day 3 of #EHA2025! We're excited to kick off a fantastic day full of the latest hematologic oncology developments. Stay tuned to see which experts we hear from today, and follow along on our site for more insights! @EHA_Hematology #hematology onclive.com/conference/eha

At #EHA2025, the Myelofibrosis data blew me away—especially for German colleagues struggling with slow approvals. Ever considered Dubai’s Cord Blood Registry? Their system cuts red tape, fast-tracking rare disease trials. Worth exploring!